Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8791 to 8805 of 8903 results

  1. Over 1000 people with advanced breast cancer set to benefit from new once-a-day tablet

    We’ve issued final draft guidance recommending a new once-a-day tablet that is set to benefit around 1,100 people with a type of advanced breast cancer.

  2. Public consultation launched on changes to NICE's Highly Specialised Technologies routing criteria

    NICE is proposing changes to its routing criteria for Highly Specialised Technologies (HST) to ensure more consistent, predictable and transparent decisions.

  3. New price deal paves way for NICE approval of treatment for rare genetic condition

    A new treatment for Duchenne muscular dystrophy (DMD) is set to be available to around 1,700 people in England following positive final draft guidance from NICE published today.

  4. New joint guideline recommends prescribing combination treatments for people with newly diagnosed asthma

    For the first time, the British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) have collaborated to develop a UK-wide asthma guideline.

  5. NICE responds to failure of talks to reach price agreement on Enhertu

    Talks with the makers of Enhertu have ended without agreement, meaning guidance that does not recommend Enhertu for advanced breast cancer will remain unchanged.

  6. The key to effective shared decision making is to involve people in meaningful conversations about their choices

    "Tell me and I forget. Teach me and I remember. Involve me and I learn." Benjamin Franklin.

  7. More people with rare genetic disorder eligible for nusinersen

    Following a review of data collected as part of the Managed Access Agreement, more people with spinal muscular atrophy (SMA) are to benefit from nusinersen.

  8. Public consultation on updates to health technology evaluations manual

    A public consultation marking the first update to NICE's health technology evaluations manual is now open.

  9. Evidence Evusheld is effective in protecting vulnerable adults against variants lacking, as NICE announces new rapid update process for COVID-19 medicines

    NICE issues draft guidance for public consultation which does not recommend Evusheld for preventing COVID-19 in some adults.

  10. Hundreds of children with type 2 diabetes to be offered choice of two life changing technologies

    Children with type 2 diabetes who currently manage their condition with the stressful task of finger prick testing several times a day could be offered a choice between two ‘life changing’ technologies to virtually automate the process.

  11. Draft guidance recommends healthcare professionals ask people about gambling

    Health professionals should ask people about gambling if they attend a health check or GP appointment with a mental health problem, in a similar way to how people are asked about their smoking and alcohol consumption, according to new draft guidance.

  12. Supporting innovation: clear approval pathways and evidence standards for AI-driven digital health technologies

    Jeanette Kusel explains how we are working in partnership to improve patient access to the best digital health innovations.

  13. NICE partners with international health technology assessment bodies

    Six health technology assessment (HTA) bodies from three continents are to collaborate on a range of topics that will benefit people accessing healthcare around the world.

  14. Updated guideline recommends more treatment choices for menopause symptoms

    New evidence shows that cognitive behavioural therapy (CBT) can help reduce menopause symptoms including hot flushes and night sweats, depressive symptoms and problems sleeping NICE has said in its draft updated guideline on menopause published today (17 November 2023).

  15. NICE signs up to join the GetReal Institute

    NICE and the GetReal Institute: facilitating the adoption and implementation of real-world evidence in health care decision-making.